HIV SEROPREVALENCE (% 0F POPULATION)
Capital/Major City
Country Low Risk High Risk
CARIBBEAN
Antigua and Barbuda 1.7
Bahamas 3.6 18.4
Barbados 1.2 4.7
British Virgin Islands 2.8 *
Cayman Islands .0
Cuba .0 .0
Dominican Republic 1.3 5.0
Grenada .0 2.4 *
Haiti 15.7 41.9
Jamaica .3 14.6 *
Martinique .5 38.9 *
Montserrat .0
St. Kitts and Nevis 2.0
St. Lucia .0 1.2
St. Vincent and Grens. .2 1.4
Trinidad and Tobago .2 14.7
CENTRAL AMERICA
Costa Rica 1.1 4.3
El Salvador .3 * 2.2
Guatemala .0 .7
Honduras .2 19.8
Nicaragua .0 1.6 *
Panama .0
SOUTH AMERICA
Argentina .3 6.3
Bolivia .0 .0
Brazil .8 24.0
Chile .0 1.0
Colombia .1 14.6
Ecuador .0 * .5
Guyana 6.9 25.0 *
Paraguay .0 .1
Peru .1 .3
Suriname .8 2.6
Uruguay .1 5.6
Venezuela .1 6.1 *
Mexico .1 * 2.2
Source: U.S. Bureau of the Census: 1994 HIV/AIDS
Surveillance Data Base
Definition: HIV Seroprevalence means tested positive
for HIV I antibodies
* Data are best available but are not necessarily
reliable due to small sample size (<100)